Pharming Group NV (PHAR) — Long-term Investment Intensity
Pharming Group NV (PHAR) has a Long-term Investment Intensity of 1.7% as of December 2025. Long-term investments of $8.65 Million represent 1.7% of total assets of $499.81 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See PHAR net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Pharming Group NV Long-term Investment Intensity (2019–2025)
This chart shows how Pharming Group NV's Long-term Investment Intensity has evolved across 7 annual periods from 2019 to 2025. As of December 2025, the intensity stands at 1.7%, reflecting long-term investments of $8.65 Million against total assets of $499.81 Million USD. Also explore Pharming Group NV balance sheet assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Pharming Group NV (2019–2025)
The table below presents the year-by-year Long-term Investment Intensity for Pharming Group NV from 2019 to 2025, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Pharming Group NV (PHAR) total market value.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 1.7% | $8.65 Million | $499.81 Million | ▲ +0.7 pp |
| 2024 | 1.1% | $4.23 Million | $399.99 Million | ▼ -1.2 pp |
| 2023 | 2.2% | $10.40 Million | $462.85 Million | ▼ 0.0 pp |
| 2022 | 2.3% | $9.73 Million | $425.80 Million | ▲ +0.1 pp |
| 2021 | 2.2% | $8.79 Million | $397.31 Million | ▲ +0.5 pp |
| 2020 | 1.7% | $5.80 Million | $342.55 Million | ▼ -0.5 pp |
| 2019 | 2.2% | $5.51 Million | $255.91 Million | — |